Basit öğe kaydını göster

dc.contributor.authorONCEL, M
dc.contributor.authorPEYMAN, GA
dc.date.accessioned2021-03-05T09:42:13Z
dc.date.available2021-03-05T09:42:13Z
dc.date.issued1993
dc.identifier.citationONCEL M., PEYMAN G., "INTRAVITREAL PENETRATION OF ORAL PEFLOXACIN IN HUMANS", INTERNATIONAL OPHTHALMOLOGY, cilt.17, ss.217-222, 1993
dc.identifier.issn0165-5701
dc.identifier.otherav_9f1f31b8-48e1-4ca9-90fc-049e15183366
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/106838
dc.identifier.urihttps://doi.org/10.1007/bf01007743
dc.description.abstractWe measured vitreous and serum levels of pefloxacin after oral administration. Twenty patients with retinal detachments undergoing vitrectomy were recruited into this study. Each patient received 400 mg pefloxacin orally 1 to 12 hours before vitrectomy. Vitreous fluid (0.1 mL) was aspirated at surgery. Vitreous levels of pefloxacin were determined by high-performance liquid chromatography. Six hours after oral administration, an average level of 1.37 mug/mL of pefloxacin was measured in the vitreous samples. These levels were well above the minimum inhibitory concentration (MIC) for most organisms termed sensitive to pefloxacin. Oral administration of pefloxacin may play an important role in the prevention or management of endophthalmitis.
dc.language.isoeng
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titleINTRAVITREAL PENETRATION OF ORAL PEFLOXACIN IN HUMANS
dc.typeMakale
dc.relation.journalINTERNATIONAL OPHTHALMOLOGY
dc.contributor.department, ,
dc.identifier.volume17
dc.identifier.issue4
dc.identifier.startpage217
dc.identifier.endpage222
dc.contributor.firstauthorID114493


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster